Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
J Exp Med ; 190(3): 399-410, 1999 Aug 02.
Article in English | MEDLINE | ID: mdl-10430628

ABSTRACT

The role of apoptosis in affinity maturation was investigated by determining the affinity of (4-hydroxy-3-nitrophenyl)acetyl (NP)-specific antibody-forming cells (AFCs) and serum antibody in transgenic mice that overexpress a suppressor of apoptosis, Bcl-xL, in the B cell compartment. Although transgenic animals briefly expressed higher numbers of splenic AFCs after immunization, the bcl-xL transgene did not increase the number or size of germinal centers (GCs), alter the levels of serum antibody, or change the frequency of NP-specific, long-lived AFCs. Nonetheless, the bcl-xL transgene product, in addition to endogenous Bcl-xL, reduced apoptosis in GC B cells and resulted in the expansion of B lymphocytes bearing VDJ rearrangements that are usually rare in primary anti-NP responses. Long-lived AFCs bearing these noncanonical rearrangements were frequent in the bone marrow and secreted immunoglobulin G(1) antibodies with low affinity for NP. The abundance of noncanonical cells lowered the average affinity of long-lived AFCs and serum antibody, demonstrating that Bcl-xL and apoptosis influence clonal selection/maintenance for affinity maturation.


Subject(s)
Antibody Affinity/genetics , Apoptosis/genetics , Apoptosis/immunology , Germinal Center/cytology , Germinal Center/immunology , Proto-Oncogene Proteins c-bcl-2/genetics , Animals , Antibodies/blood , Antibody Formation/genetics , Antibody-Producing Cells/cytology , Antibody-Producing Cells/immunology , Antibody-Producing Cells/metabolism , Antibody-Producing Cells/pathology , B-Lymphocyte Subsets/cytology , B-Lymphocyte Subsets/immunology , B-Lymphocyte Subsets/metabolism , B-Lymphocyte Subsets/pathology , Bone Marrow Cells/immunology , Bone Marrow Cells/pathology , Cell Differentiation/genetics , Cell Differentiation/immunology , Cell Survival/genetics , Cell Survival/immunology , Cells, Cultured , Gene Rearrangement, B-Lymphocyte, Heavy Chain/genetics , Immunoglobulin Variable Region/genetics , Lymphocyte Count , Mice , Mice, Inbred C57BL , Mice, Transgenic , Molecular Sequence Data , Proto-Oncogene Proteins c-bcl-2/biosynthesis , Proto-Oncogene Proteins c-bcl-2/immunology , Spleen , Transgenes/immunology , bcl-X Protein
2.
J Immunol ; 162(3): 1460-5, 1999 Feb 01.
Article in English | MEDLINE | ID: mdl-9973402

ABSTRACT

The induction of clonal anergy in a T cell inhibits IL-2 secretion because of the development of a proximal signal transduction defect. Fusion of anergic murine T cells to human Jurkat T leukemia cells and formation of heterokaryons failed to result in a complementation of this signaling defect and restoration of murine IL-2 mRNA inducibility. Instead, signal transduction to the human IL-2 gene became disrupted. Heterokaryons formed by the fusion of anergic murine T cells to normal murine T cells also failed to accumulate intracellular IL-2 protein in response to stimulation either with the combination of CD3 and CD28 mAbs or with ionomycin plus a protein kinase C-activating phorbol ester. The results argue against a loss-of-function signaling defect as the sole basis for clonal anergy induction and document the presence of a dominant-acting repressor molecule that inhibits signal transduction to the IL-2 gene within viable anergic T cells.


Subject(s)
Clonal Anergy , Interleukin-2/genetics , T-Lymphocytes/immunology , Animals , Base Sequence , Cell Fusion , Cell Line , Clonal Anergy/drug effects , Clonal Anergy/genetics , DNA Primers/genetics , Gene Expression Regulation/drug effects , Genetic Complementation Test , Humans , Ionomycin/pharmacology , Jurkat Cells , Lymphocyte Activation/genetics , Mice , Models, Biological , Repressor Proteins/immunology , Reverse Transcriptase Polymerase Chain Reaction , T-Lymphocytes/drug effects , Tetradecanoylphorbol Acetate/pharmacology , Transcriptional Activation
3.
Immunol Rev ; 165: 301-18, 1998 Oct.
Article in English | MEDLINE | ID: mdl-9850869

ABSTRACT

Exposure of mature CD4+ T cells in the peripheral immune system to peptide-antigen/MHC complexes in the absence of a threat of infection induces tolerance to the antigen as a result of both a decreased clonal frequency (peripheral deletion) and the induction of proliferative unresponsiveness (clonal anergy) in the survivors. Interestingly, Th 1-like effector functions are not automatically blocked after the development of clonal anergy. Thus, anergic T cells have the capacity to mediate Th 1-like helper activities if allowed to accumulate to high frequency. In this article, we examine those factors important to the development of tolerance versus immunity against protein antigen, and speculate on the relationship that exists between effective peripheral tolerance induction and the avoidance of autoimmune disease.


Subject(s)
Autoimmunity/immunology , Clonal Anergy/immunology , Animals , CD4-Positive T-Lymphocytes/immunology , Humans , Immune Tolerance/immunology , Mice , Mice, Nude , Proteins/immunology , T-Lymphocytes, Regulatory/immunology
4.
J Immunol ; 161(5): 2168-77, 1998 Sep 01.
Article in English | MEDLINE | ID: mdl-9725208

ABSTRACT

Clonal anergy in Ag-specific CD4+ T cells is shown in these experiments to inhibit IL-2 production and clonal expansion in vivo. We also demonstrate that the defect in IL-2 gene inducibility can be achieved in both naive and Th1-like memory T cells when repeatedly exposed to aqueous peptide Ag. Nevertheless, this induction of clonal anergy did not interfere with the capacity of naive T cells to differentiate into Th1-like effector cells, nor did it prevent such helper cells from participating in T-dependent IgG2a anti-hapten responses and delayed-type hypersensitivity reactions. Thus, clonal anergy can contribute to the development of Ag-specific immune tolerance by limiting the size of a Th cell population, but not by disrupting its effector function.


Subject(s)
Clonal Anergy/immunology , Th1 Cells/immunology , Adoptive Transfer , Animals , Antigens/administration & dosage , Antigens/immunology , Cell Differentiation/immunology , Cell Movement/immunology , Clonal Anergy/genetics , Hypersensitivity, Delayed/immunology , Immunoglobulin G/biosynthesis , Immunophenotyping , Injections, Intravenous , Interferon-gamma/biosynthesis , Interleukin-2/biosynthesis , Interphase/immunology , Lymph Nodes/cytology , Lymph Nodes/immunology , Lymphocyte Activation , Lymphocyte Cooperation , Mice , Mice, Inbred BALB C , Mice, Nude , Mice, Transgenic , Ovalbumin/administration & dosage , Ovalbumin/immunology , Peptide Fragments/administration & dosage , Peptide Fragments/immunology , Receptors, Antigen, T-Cell/genetics , T-Lymphocyte Subsets/immunology , T-Lymphocyte Subsets/metabolism , T-Lymphocyte Subsets/transplantation , Th1 Cells/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...